Compare StocksABT vs CMCSA

Abbott Laboratories (ABT) vs Comcast Corporation (CMCSA): Which Is the Better Buy in 2026?

As of 2026-08-03, ABT is overvalued at $106, with a DCF intrinsic value of $89 and a margin of safety of -18%. CMCSA is undervalued at $24, with an intrinsic value of $78 and a margin of safety of 69%. Of the two, CMCSA has the wider margin of safety.

ABT
Abbott Laboratories
$105.70
VS
CMCSA
Comcast Corporation
$23.96

Rewards

ABT
  • Abbott Laboratories scores 86/100 on the Economic Moat Score (Wide Moat), with margin stability as the strongest competitive dimension.
  • Altman Z-Score of 5.60 indicates very low bankruptcy risk — the company is firmly in the safe zone.
CMCSA
  • Gross margin of 69.4% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • Free cash flow has grown at a 15.0% CAGR over the past 4 years, demonstrating strong earnings power growth.
  • Share count has been reduced by 15% over the past 4 years through buybacks, increasing each share's claim on earnings.

Risks

ABT
  • Trailing P/E of 34.2x is 26% above the historical average of 27.2x — the stock trades at a premium to its own history.
  • PEG ratio of 2.13 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
CMCSA
  • PEG ratio of 142.98 indicates the stock is expensive relative to its expected growth — the market may be pricing in more growth than analysts project.
  • Altman Z-Score of 1.37 places the company in the distress zone — financial patterns resemble those of companies that experienced bankruptcy.

Key Valuation Metrics

Learn more →
ABT
CMCSA
Valuation
$7.21B
Free Cash Flow
$19.23B
3.94%
FCF Yield
22.62%
34.21
Trailing P/E
7.68
17.43
Forward P/E
6.61
Quality & Moat
6.41%
ROIC
9.43%
10.58%
ROE
11.49%
56.85%
Gross Margin
69.39%
2.13
PEG Ratio
142.98
Balance Sheet Safety
0.52
Net Debt / Equity
0.92
N/A
Interest Coverage
N/A
2.32
Net Debt / EBITDA
2.43
2.38%
Dividend Yield
5.51%
ABT: 2Ties: 2CMCSA: 8
ABTCMCSA

Historical Fundamentals

Learn more →
ABT

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

CMCSA

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
ABT
$1.89
created per $1 retained over 3 years
Value Creator
Σ Retained
$14.14B
Δ Market Cap
+$26.79B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
CMCSA
$-1.01
created per $1 retained over 3 years
Market Cap Declined
Σ Retained
$37.10B
Δ Market Cap
$-37.35B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
ABT
18.2% Overvalued
Price is 18.2% above estimated fair value
Current Price: $105.70
Fair Value: $89.41
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
CMCSA
69.2% Margin of Safety
Price is 69.2% below estimated fair value
Current Price: $23.96
Fair Value: $77.78
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
ABT

What growth rate is the market pricing in at $106?

+12.3%
Market-Implied Owner Earnings Growth
Standard FCF implies +12.8%

The market implies +12.3% Owner Earnings growth, above historical trends.

Standard FCF implies a demanding +12.8%, reflecting heavy growth investment.

CMCSA

What growth rate is the market pricing in at $24?

-5.6%
Market-Implied Owner Earnings Growth
Standard FCF implies -3.8%

The market implies -5.6% Owner Earnings growth, below historical trends — potential opportunity.

Standard FCF implies a more demanding -3.8%, reflecting heavy growth investment expected to generate future returns.

Economic Moat Score

Learn more →
ABT
86/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Margin Stability is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
CMCSA
67/100
Narrow Moat
70+ Wide · 40-69 Narrow · <40 None

Narrow moat with margin stability as the key competitive advantage. Improving roic consistency would strengthen the moat.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
ABT
-2.48
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
CMCSA
-2.73
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
ABT
Insiders 0.5%Institutions 83.0%Retail & Other 16.5%
No. of Institutional Holders3,843
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
CMCSA
Insiders 0.7%Institutions 94.2%Retail & Other 5.0%
No. of Institutional Holders2,627
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
ABT
1
Buys (3M)
5
Buys (12M)
Total value (12M): $4.40M
STRATTON JOHN G.
Director
$173,640
@ $86.82 · 2026-05-07
STARKS DANIEL J
Director
$926,537
@ $92.65 · 2026-04-27
BOUDREAU PHILIP P
Chief Financial Officer
$201,300
@ $91.50 · 2026-04-23
STARKS DANIEL J
Director
$1.09M
@ $108.73 · 2026-02-04
FORD ROBERT B.
Chief Executive Officer
$2.01M
@ $107.13 · 2026-01-23
Open market purchases · includes direct & indirect ownership · excludes option exercises
CMCSA
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
ABT
0
Sells (3M)
8
Sells (12M)
Total value (12M): $1.44M
SALVADORI DANIEL GESUA SIVE
Officer
$102,288
@ $115.58 · 2026-03-02
MCCOY JOHN A. JR
Officer
$67,614
@ $115.58 · 2026-03-02
MORRONE LOUIS H
Officer
$132,224
@ $115.58 · 2026-03-02
SHROFF ERIC
Officer
$81,946
@ $115.58 · 2026-03-02
CUSHMAN ELIZABETH C
General Counsel
$30,398
@ $115.58 · 2026-03-02
MORELAND MARY K
Officer
$70,851
@ $115.58 · 2026-03-02
SHROFF ERIC
Officer
$203,043
@ $128.02 · 2025-11-25
BOUDREAU PHILIP P
Chief Financial Officer
$746,758
@ $134.55 · 2025-08-08
BLOUNT SALLY E
Director
$337,116
@ $129.66 · 2025-04-30
EARNHARDT LISA D
President
$12.23M
@ $133.83 · 2025-03-07
MCCOY JOHN A. JR
Officer
$77,652
@ $138.17 · 2025-03-03
MORRONE LOUIS H
Officer
$153,507
@ $138.17 · 2025-03-03
SHROFF ERIC
Officer
$77,652
@ $138.17 · 2025-03-03
MORELAND MARY K
Officer
$109,292
@ $138.17 · 2025-03-03
WAINER ANDREA F
Officer
$131,123
@ $138.17 · 2025-03-03
FORD ROBERT B.
Chief Executive Officer
$37.44M
@ $131.17 · 2025-02-05
SALVADORI DANIEL GESUA SIVE
Officer
$3.05M
@ $128.50 · 2025-01-30
ALLEN HUBERT L.
Officer
$24.34M
@ $128.26 · 2025-01-30
ALLEN HUBERT L.
Officer
$18.42M
@ $117.04 · 2024-10-21
FORD ROBERT B.
Chief Executive Officer
$16.49M
@ $116.41 · 2024-09-12
MCCOY JOHN A. JR
Officer
$3,100
@ $114.81 · 2024-09-04
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
CMCSA
0
Sells (3M)
2
Sells (12M)
Total value (12M): $388,385
ARMSTRONG JASON S
Chief Financial Officer
$142,617
@ $31.73 · 2026-03-05
NAKAHARA ASUKA
Director
$245,768
@ $29.70 · 2026-02-03
ROBERTS BRIAN L
Chief Executive Officer
$20.06M
@ $42.73 · 2024-11-27
BACON KENNETH J
Director
$625,093
@ $43.39 · 2024-11-22
ARMSTRONG JASON S
Chief Financial Officer
$1.04M
@ $44.84 · 2024-11-06
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
ABT
FearGreed
😐Neutral(53/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
CMCSA
FearGreed
😐Neutral(41/100)

"Market is pricing this stock without strong emotion in either direction"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
ABT
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (53)
CMCSA
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Neutral (41)
View ABT Full AnalysisView CMCSA Full Analysis

Frequently Asked Questions: ABT vs CMCSA

Is Abbott Laboratories or Comcast Corporation more undervalued in 2026?

Based on our discounted cash flow model, CMCSA trades at a 69.2% margin of safety (intrinsic value $78 vs. price $24), compared to ABT's -18.2% margin of safety (intrinsic $89 vs. $106).

Which stock has a wider economic moat, Abbott Laboratories or Comcast Corporation?

ABT scores 86/100 (Wide moat), while CMCSA scores 67/100 (Narrow moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is Comcast Corporation in financial distress?

CMCSA's Altman Z-Score of 1.4 places it in the Distress zone, signaling elevated bankruptcy risk. ABT scores 5.6 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which company has better free cash flow, Abbott Laboratories or Comcast Corporation?

Comcast Corporation (CMCSA) generates a 22.6% free cash flow yield, compared to Abbott Laboratories's 3.9%. A higher FCF yield means the business converts more of its market value into cash that can be returned to shareholders or reinvested.

Which stock has higher return on invested capital, Abbott Laboratories or Comcast Corporation?

CMCSA earns 9.4% ROIC versus ABT's 6.4%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, Abbott Laboratories's or Comcast Corporation's?

CMCSA's dividend earns a safety score of 94/100 (Very Safe), compared to ABT's 84/100 (Very Safe). CMCSA has raised its dividend for 3 consecutive years.